Ask about Upper Face Wrinkle Treatment Near Norbiton
Expression lines across the forehead, between the eyebrows and around the outer corners of the eyes develop through repeated facial movement. Changes in collagen, skin elasticity and sun exposure can gradually make these lines more noticeable, including while the face is relaxed.
Our upper face wrinkle treatment near Norbiton begins with a personalised consultation rather than a predetermined injection package. Dr Laura Geige examines how the forehead, brows and eye area move together before advising whether prescription treatment, medical-grade skincare or another skin-quality approach may be appropriate.
The principal concerns assessed are horizontal forehead lines, vertical glabellar or frown lines and crow’s feet around the outer eyes. These areas are closely connected, which means treating one muscle group without considering the others may alter brow position or create an unbalanced pattern of movement.
Treatment takes place at It’s Me & You Skin Clinic in Kingston upon Thames. Dr Laura Geige is the clinic’s Medical Director and Senior Aesthetics Practitioner. She is a GDC-registered dentist with a Level 7 qualification in Aesthetic Medicine and experience in facial injectables, skin rejuvenation and cosmetic dermatology.
The purpose is usually to soften selected expression lines while preserving a natural degree of facial movement. A completely immobile forehead or noticeably frozen expression is not treated as the automatic objective.
Please contact the clinic before purchasing or booking. Medical suitability, prescribing requirements, appointment availability and the appropriate treatment areas must be confirmed first. A consultation does not guarantee that an injectable treatment will be prescribed or administered during the same visit.
Important Prescription and Advertising Information
Medicines used to reduce upper-face muscle movement are prescription-only medicines in the UK. They cannot legally be advertised directly or indirectly to members of the public, including through brand-led treatment names, promotional before-and-after imagery or price offers linked to a particular medicine.
This page is therefore centred on the concern, clinical consultation and treatment pathway rather than promoting a particular prescription product. The medicine, dose and placement can be selected only after an appropriate prescriber has considered the patient’s medical history, anatomy and treatment objectives.
The MHRA also advises patients to ensure that any product administered is authorised for use in the UK and obtained through legitimate regulated channels. Unauthorised or counterfeit products do not provide the same safeguards for quality and safety.













